Our research analysts offer in-depth analysis of stocks across the market-cap spectrum, albeit with a particular focus on small- and midcap companies. We strive to identify best-of-breed companies that have promising long-term outlooks with attractive, sustainable earnings growth rates.

While resale historically has been a smaller portion of the second-hand market, the more recent emergence of online resale, including consignment platforms, has helped push the market into a faster stage of growth, poised to take greater share.

P&C insurance analyst Adam Klauber believes legacy insurers should increasingly lose relevance and value over the next decade as structural impediments limit their ability to pivot toward evolving industry dynamics.

Over the last 10 years, major changes in diabetes device sales have been driven by those solutions that have demonstrated an ability to improve glycemic control (as measured by HbA1c reduction or time-in-range).

Technology analyst Jason Ader has written extensively about the rise of containers and Kubernetes in the context of next-generation, microservices-based application architectures, and now attempts to demystify the term multicloud and delve into the central role of Kubernetes in enabling enterprises to pursue a multicloud deployment model.

Technology analyst Mathew Pfau believes that digital freight matching (DFM) is a potentially massive market that has garnered a lot of attention from venture capital and private equity over the past several years.

With the robust efficacy of autologous CAR-T-cell therapies to date, the focus has shifted to commercial issues related to vein-to-vein time, manufacturing variability, shipping/chain-of-custody issues, and scalability over the long term. Allogeneic cell therapies (derived from a healthy donor) have the potential to address these issues by providing an enhanced speed to patient, availability, decreased cell variability, and streamlined manufacturing efficiencies.

This conference showcases the scientists and clinicians driving the advancements in the field of cancer immunotherapy and is designed to facilitate discussion with the audience to further elucidate underlying mechanisms of biology and promising novel therapies.

Companies are increasingly turning to low-code/no-code application development platforms that democratize the development process and give business users the ability to develop applications themselves with minimal or no assistance from IT.

Healthcare analyst John Kreger attended CPhI Worldwide, the world’s largest trade fair for pharmaceutical contract manufacturing. At the event, he had the opportunity to meet with public and private players in the contract development and manufacturing (CDMO) space. 

The commercial real estate (CRE) services industry is growing relatively quickly and represents a broad variety of services provided to property managers, investors, and tenants/occupiers of commercial real estate.

 1 2